Tenet Healthcare Corporation
Cash Flow Statement
| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $1.22B | $1.05B | $906.0M | $644.0M | $579.0M | $522.0M | $622.0M | $572.0M |
| Depreciation & Amortization | $217.0M | $215.0M | $229.0M | $231.0M | $218.0M | $208.0M | $206.0M | $193.0M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $27.0M | $40.0M | $40.0M | $44.0M | $43.0M | $39.0M | $40.0M | $36.0M |
| Stock-Based Compensation | $35.0M | $44.0M | $25.0M | $25.0M | $38.0M | $20.0M | $21.0M | $15.0M |
| Net Cash from Operating Activities | $1.28B | $585.0M | $1.64B | $731.0M | $1.06B | $936.0M | $815.0M | $-331.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $198.0M | $168.0M | $180.0M | $364.0M | $280.0M | $193.0M | $173.0M | $330.0M |
| Business Acquisitions | $71.0M | $9.0M | $121.0M | $42.0M | $119.0M | $120.0M | $27.0M | $47.0M |
| Net Cash from Investing Activities | $-298.0M | $-203.0M | $-317.0M | $-389.0M | $-385.0M | $-314.0M | $-187.0M | $-372.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $255.0M | $1.04B | $318.0M | $198.0M | $93.0M | $747.0M | $348.0M | $0 |
| Net Cash from Financing Activities | $-479.0M | $-1.18B | $-1.24B | $-434.0M | $-323.0M | $-996.0M | $-648.0M | $-372.0M |
| Net Change in Cash | $504.0M | $-797.0M | $84.0M | $-92.0M | $350.0M | $-374.0M | $-20.0M | $-1.08B |
| Free Cash Flow | $1.08B | $417.0M | $1.46B | $367.0M | $778.0M | $743.0M | $642.0M | $-661.0M |